Skip to content
DefDex

Federal award

OXYHEAL HEALTH GROUP, INC.

W911QY09C0180

Contract

Obligated and Ceiling

Obligated (net)
$10,501,456.30
Ceiling (potential value, not spending)
$10,505,296.34
Current value
$10,501,456.34
Gross positive obligations
$10,501,456.30

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
OXYHEAL HEALTH GROUP, INC. · TD1JJBQ29LL4
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
OXYHEAL HEALTH GROUP, INC. · TD1JJBQ29LL4
Awarding agency
Department of War · sub-agency 2100 · office W911QY
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
AJ11 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Industry (NAICS)
541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
PIID
W911QY09C0180
Award type code
D
Actions
15 · Sep 29, 2009 to Jun 20, 2012
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History15

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 20, 2012FY2012P00014M$0.00
—
Dec 28, 2011FY2012P00013B$1,639,028.10
—
Sep 16, 2011FY2011P00012M$0.00
—
Jun 29, 2011FY2011P00011M$0.00
—
Jun 15, 2011FY2011P00010G$1,279,488.00
—
Jun 7, 2011FY2011P00009G$0.00
—
Feb 9, 2011FY2011P00008G$2,482,024.20
—
Jan 24, 2011FY2011P00007M$0.00
—
Dec 22, 2010FY2011P00006B$17,107.00
—
Aug 31, 2010FY2010P00005M$0.00
—
Apr 26, 2010FY2010P00004B$0.00
—
Feb 1, 2010FY2010P00003M$250,080.00
—
Jan 8, 2010FY2010P00002M$0.00
—
Sep 30, 2009FY2009P00001M$2,833,729.00
—
Sep 29, 2009FY20090—$2,000,000.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.